For research use only. Not for therapeutic Use.
Bucladesine sodium salt (CAT: I002213), also known as di-butyryl cyclic adenosine monophosphate (db-cAMP), is a cell-permeable analog of cyclic adenosine monophosphate (cAMP). It acts as a potent activator of protein kinase A (PKA) and mimics the intracellular effects of cAMP. The bucladesine sodium salt is commonly used in research to study the role of cAMP signaling pathways in various cellular processes. It has been investigated for its potential therapeutic applications in cardiovascular diseases, neurodegenerative disorders, and cancer. The bucladesine sodium salt is a valuable tool for understanding cAMP-mediated signaling and its impact on cellular physiology and disease processes.
Catalog Number | I002213 |
CAS Number | 16980-89-5 |
Synonyms | sodium (4aR,6S,7R,7aR)-6-(6-butyramido-9H-purin-9-yl)-7-(butyryloxy)tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide |
Molecular Formula | C18H23N5O8P • Na |
Purity | ≥95% |
Target | TGF-beta/Smad |
Solubility | H2O: 40 mg/mL |
Storage | Store at -20°C |
InChIKey | KRBZRVBLIUDQNG-JBVYASIDSA-M |
Reference | <p style=/line-height:25px/> |